Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

ARGATROBAN

ARGATROBAN

Standard Dose
250MG/2.5ML (100MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ARGATROBAN is listed in Drugs@FDA under application 206698 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ARGATROBAN Form and strength INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML) Sponsor AMNEAL PHARMS CO Submission history Latest submission status date: 2018-01-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview ARGATROBAN is listed in Drugs@FDA under application 206698 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ARGATROBAN Form and strength INJECTABLE;INJECTION - 250MG/2.5ML (100MG/ML) Sponsor AMNEAL PHARMS CO Submission history Latest submission status date: 2018-01-26 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.